Results
1 -
10 of
64
(Click
here to explore results)
- Anti-multiple myeloma potential of resynthesized belinostat derivatives: an experimental study on cytotoxic activity, drug combination, and docking studies. Hong Phuong Nguyen, Quang De Tran, Cuong Quoc Nguyen, Tran Phuong Hoa, Tran Duy Binh, Huynh Nhu Thao, Bui Thi Buu Hue, Nguyen Trong Tuan, Quang Le Dang, Nguyen Quoc Chau Thanh, Nguyen Van Ky, Minh Quan Pham, Su-Geun Yang
, RSC Adv.
, 2022
, 12
, 22108
- Belinostat loaded lipid–polymer hybrid nanoparticulate delivery system for breast cancer: improved pharmacokinetics and biodistribution in a tumor model. Kommera Sai Pradyuth, Shubham A. Salunkhe, Arihant Kumar Singh, Deepak Chitkara, Anupama Mittal
, J. Mater. Chem. B
, 2023
, 11
, 10859
- Novel histone deacetylase 6 inhibitors using benzimidazole as caps for cancer treatment. Phuong Hong Nguyen, Bui Thi Buu Hue, Minh Quan Pham, Tran Phuong Hoa, Quang De Tran, Hosun Jung, Le Trong Hieu, Nguyen Cuong Quoc, Hong Vinh Quang, Nguyen Phu Quy, Hye Jin Yoo, Su-Geun Yang
, New J. Chem.
, 2023
, 47
, 7622
- Cytotoxicity of targeted PLGA nanoparticles: a systematic review. Hock Ing Chiu, Nozlena Abdul Samad, Lizhen Fang, Vuanghao Lim
, RSC Adv.
, 2021
, 11
, 9433
- Prodrug strategies for targeted therapy triggered by reactive oxygen species. Jorge Peiró Cadahía, Viola Previtali, Nikolaj S. Troelsen, Mads H. Clausen
, Med. Chem. Commun.
, 2019
, 10
, 1531
- Chimerically designed HDAC- and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGFR, HER2 and histone deacetylases. Thomas Beckers, Siavosh Mahboobi, Andreas Sellmer, Matthias Winkler, Emerich Eichhorn, Herwig Pongratz, Thomas Maier, Thomas Ciossek, Thomas Baer, Gerhard Kelter, Heinz-Herbert Fiebig, Mathias Schmidt
, Med. Chem. Commun.
, 2012
, 3
, 829
- Macrocyclization via remote meta-selective C–H olefination using a practical indolyl template. Pengfei Zhang, Zhiwei Jiang, Zhoulong Fan, Guoshuai Li, Qingxue Ma, Jun Huang, Jinghong Tang, Xiaohua Xu, Jin-Quan Yu, Zhong Jin
, Chem. Sci.
, 2023
, 14
, 8279
- Small molecule inhibitors in pancreatic cancer. Jufeng Sun, Cecilia C. Russell, Christopher J. Scarlett, Adam McCluskey
, RSC Med. Chem.
, 2020
, 11
, 164
- Novel (E)-3-(1-substituted-1H-indazol-5-yl)-N-hydroxypropenamides as histone deacetylase inhibitors: design, synthesis and structure–activity relationships. Minh Sang Doan, Eun Jae Park, Duong Tien Anh, Do Thi Mai Dung, Le Quang-Bao, Pham-The Hai, Dao Thi Kim Oanh, Truong Thanh Tung, Ik Ho Na, Joo Hee Kwon, Jong Soon Kang, Sang-Bae Han, Dinh Thi Thanh Hai, Nguyen-Hai Nam
, New J. Chem.
, 2023
, 47
, 4478
- Glycosidase activated prodrugs for targeted cancer therapy. Harlei Martin, Laura Ramírez Lázaro, Thorfinnur Gunnlaugsson, Eoin M. Scanlan
, Chem. Soc. Rev.
, 2022
, 51
, 9694